ORAGENICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
ORAGENICS, INC. (OGEN) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $173.03 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-13
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $173.03K.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $190.62K.
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $208.00K; Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount as first filed $21.15K.
- 2024-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $160.93K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount as first filed |
|---|---|---|
| 2026-06-30 | $173.03K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $190.62K 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $208.00K 10-K · filed 2026-03-16 | $21.15K 10-K · filed 2025-03-14 |
| 2024-06-30 | $160.93K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $223.57K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $287.86K 10-K · filed 2024-03-29 | |
| 2023-09-30 | $126.90K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $118.87K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $182.47K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $139.42K 10-K · filed 2023-04-17 | |
| 2022-09-30 | $517.72K 10-Q/A · filed 2023-04-14 | |
| 2022-06-30 | $436.16K 10-Q/A · filed 2023-04-14 | |
| 2022-03-31 | $311.53K 10-Q/A · filed 2023-04-14 | |
| 2021-09-30 | $414.57K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $442.86K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.16M 10-Q · filed 2021-05-03 | |
| 2020-09-30 | $490.46K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $578.53K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $709.98K 10-Q · filed 2020-05-15 | |
| 2018-12-31 | $496.45K 10-K · filed 2019-03-29 | |
| 2017-12-31 | $273.18K 10-K · filed 2018-02-16 | |
| 2016-12-31 | $365.74K 10-K · filed 2017-02-27 | |
| 2015-12-31 | $563.22K 10-K · filed 2016-03-30 | |
| 2014-12-31 | $150.39K 10-K · filed 2015-02-27 | |
| 2013-12-31 | $180.84K 10-K · filed 2014-02-28 | |
| 2012-12-31 | $223.35K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |